Influence of pretransplant inflammatory bowel disease on the outcome of allogeneic hematopoietic stem cell transplantation: a matched-pair analysis study from the Transplant Complications Working Party (TCWP) of the EBMT

[1]  A. Gennery,et al.  Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working Parties , 2019, Front. Immunol..

[2]  R. Emsley,et al.  Autologous stem cell transplantation in refractory Crohn’s disease – low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study , 2019, BMC Gastroenterology.

[3]  S. Vermeire,et al.  Autologous Haematopoietic Stem Cell Transplantation (AHSCT) in Severe Crohn’s Disease: A Review on Behalf of ECCO and EBMT , 2018, Journal of Crohn's & colitis.

[4]  M. Neunlist,et al.  Intestinal Microbiota Influences Non-intestinal Related Autoimmune Diseases , 2018, Front. Microbiol..

[5]  M. Brink,et al.  Gut microbiota injury in allogeneic haematopoietic stem cell transplantation , 2018, Nature Reviews Cancer.

[6]  Y. Naito,et al.  Gut microbiota in the pathogenesis of inflammatory bowel disease , 2018, Clinical Journal of Gastroenterology.

[7]  R. Porcher,et al.  Influence of Previous Inflammatory Bowel Disease on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: A Matched-Pair Analysis. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[8]  J. Turner,et al.  Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease , 2015, Mucosal Immunology.

[9]  H. Deeg,et al.  Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality. , 2014, Blood.

[10]  M. Sorror,et al.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. , 2005, Blood.